Literature DB >> 10688651

Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation.

Y T Tsai1, Y H Su, S S Fang, T N Huang, Y Qiu, Y S Jou, H M Shih, H J Kung, R H Chen.   

Abstract

Etk (also called Bmx) is a member of the Btk tyrosine kinase family and is expressed in a variety of hematopoietic, epithelial, and endothelial cells. We have explored biological functions, regulators, and effectors of Etk. Coexpression of v-Src and Etk led to a transphosphorylation on tyrosine 566 of Etk and subsequent autophosphorylation. These events correlated with a substantial increase in the kinase activity of Etk. STAT3, which was previously shown to be activated by Etk, associated with Etk in vivo. To investigate whether Etk could mediate v-Src-induced activation of STAT3 and cell transformation, we overexpressed a dominant-negative mutant of Etk in an immortalized, untransformed rat liver epithelial cell line, WB, which contains endogenous Etk. Dominant-negative inactivation of Etk not only blocked v-Src-induced tyrosine phosphorylation and activation of STAT3 but also caused a great reduction in the transforming activity of v-Src. In NIH3T3 cells, although Etk did not itself induce transformation, it effectively enhanced the transforming ability of a partially active c-Src mutant (c-Src378G). Furthermore, Etk activated STAT3-mediated gene expression in synergy with this Src mutant. Our findings thus indicate that Etk is a critical mediator of Src-induced cell transformation and STAT3 activation. The role of STAT3 in Etk-mediated transformation was also examined. Expression of Etk in a human hepatoma cell line Hep3B resulted in a significant increase in its transforming ability, and this effect was abrogated by dominant-negative inhibition of STAT3. These data strongly suggest that Etk links Src to STAT3 activation. Furthermore, Src-Etk-STAT3 is an important pathway in cellular transformation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688651      PMCID: PMC110821          DOI: 10.1128/MCB.20.6.2043-2054.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

1.  Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation.

Authors:  P Chaturvedi; M V Reddy; E P Reddy
Journal:  Oncogene       Date:  1998-04-02       Impact factor: 9.867

2.  Activation of Stat3 by v-Src is through a Ras-independent pathway.

Authors:  J J Liu; K Nakajima; T Hirano; H F Yang-Yen
Journal:  J Biomed Sci       Date:  1998 Nov-Dec       Impact factor: 8.410

Review 3.  Btk function in B cell development and response.

Authors:  A B Satterthwaite; Z Li; O N Witte
Journal:  Semin Immunol       Date:  1998-08       Impact factor: 11.130

4.  STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition.

Authors:  T Fukada; T Ohtani; Y Yoshida; T Shirogane; K Nishida; K Nakajima; M Hibi; T Hirano
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

5.  Tec protein-tyrosine kinase is an effector molecule of Lyn protein-tyrosine kinase.

Authors:  H Mano; Y Yamashita; A Miyazato; Y Miura; K Ozawa
Journal:  FASEB J       Date:  1996-04       Impact factor: 5.191

6.  The G protein G alpha12 stimulates Bruton's tyrosine kinase and a rasGAP through a conserved PH/BM domain.

Authors:  Y Jiang; W Ma; Y Wan; T Kozasa; S Hattori; X Y Huang
Journal:  Nature       Date:  1998-10-22       Impact factor: 49.962

7.  Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.

Authors:  R H Chen; Y H Su; R L Chuang; T Y Chang
Journal:  Oncogene       Date:  1998-10-15       Impact factor: 9.867

8.  Stat3 plays an important role in oncogenic Ros- and insulin-like growth factor I receptor-induced anchorage-independent growth.

Authors:  C S Zong; L Zeng; Y Jiang; H B Sadowski; L H Wang
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

9.  Regulation of Btk function by a major autophosphorylation site within the SH3 domain.

Authors:  H Park; M I Wahl; D E Afar; C W Turck; D J Rawlings; C Tam; A M Scharenberg; J P Kinet; O N Witte
Journal:  Immunity       Date:  1996-05       Impact factor: 31.745

10.  Tec/Bmx non-receptor tyrosine kinases are involved in regulation of Rho and serum response factor by Galpha12/13.

Authors:  J Mao; W Xie; H Yuan; M I Simon; H Mano; D Wu
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

View more
  42 in total

1.  v-Src generates a p53-independent apoptotic signal.

Authors:  B L Webb; E Jimenez; G S Martin
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK.

Authors:  Chun-Hau Chen; Won-Jing Wang; Jean-Cheng Kuo; Hsiao-Chien Tsai; Jia-Ren Lin; Zee-Fen Chang; Ruey-Hwa Chen
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

3.  Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.

Authors:  L F Lee; J Guan; Y Qiu; H J Kung
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

4.  Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3.

Authors:  Olga A Guryanova; Qiulian Wu; Lin Cheng; Justin D Lathia; Zhi Huang; Jinbo Yang; Jennifer MacSwords; Christine E Eyler; Roger E McLendon; John M Heddleston; Weinian Shou; Dolores Hambardzumyan; Jeongwu Lee; Anita B Hjelmeland; Andrew E Sloan; Markus Bredel; George R Stark; Jeremy N Rich; Shideng Bao
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

5.  Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis.

Authors:  Yun He; Yan Luo; Shibo Tang; Iiro Rajantie; Petri Salven; Matthias Heil; Rong Zhang; Dianhong Luo; Xianghong Li; Hongbo Chi; Jun Yu; Peter Carmeliet; Wolfgang Schaper; Albert J Sinusas; William C Sessa; Kari Alitalo; Wang Min
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

6.  Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.

Authors:  Hsin-Yi Chen; Che-Hung Shen; Yuh-Tyng Tsai; Feng-Chi Lin; Yuan-Ping Huang; Ruey-Hwa Chen
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

7.  Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530.

Authors:  Y-M Chang; L Bai; S Liu; J C Yang; H-J Kung; C P Evans
Journal:  Oncogene       Date:  2008-08-04       Impact factor: 9.867

8.  Etk/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: signaling partners, hierarchy and physiological significance.

Authors:  Irit Cohen; Myriam Maoz; Hagit Turm; Sorina Grisaru-Granovsky; Bella Maly; Beatrice Uziely; Einat Weiss; Rinat Abramovitch; Eithan Gross; Oded Barzilay; Yun Qiu; Rachel Bar-Shavit
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

9.  Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.

Authors:  Lesley A Mathews; Elaine M Hurt; Xiaohu Zhang; William L Farrar
Journal:  Mol Cancer       Date:  2010-10-07       Impact factor: 27.401

10.  Tyrosine kinase BMX phosphorylates phosphotyrosine-primed motif mediating the activation of multiple receptor tyrosine kinases.

Authors:  Sen Chen; Xinnong Jiang; Christina A Gewinner; John M Asara; Nicholas I Simon; Changmeng Cai; Lewis C Cantley; Steven P Balk
Journal:  Sci Signal       Date:  2013-05-28       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.